Brown Advisory Inc Mei Pharma, Inc. Transaction History

Brown Advisory Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.22 - $0.41 $660 - $1,230	-3,000 Reduced 11.05%	24,142 $5,000
Q3 2022 Nov 14, 2022	BUY	$0.41 - $0.64 $2,624 - $4,096	6,400 Added 30.86%	27,142 $10,000
Q2 2022 Nov 14, 2022	BUY	$0.42 - $0.65 $1,361 - $2,107	3,242 Added 18.53%	20,742 $13,000
Q2 2022 Aug 02, 2022	BUY	$0.42 - $0.65 $1,361 - $2,107	3,242 Added 18.53%	20,742 $13,000
Q1 2022 Nov 14, 2022	SELL	$0.54 - $2.74 $1,750 - $8,883	-3,242 Reduced 15.63%	17,500 $11,000

Q1 2022 May 09, 2022	BUY	$0.54 - $2.74 $9,450 - $47,950	17,500 New	17,500 $11,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $373M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

Stay updated on Brown Advisory Inc with notifications on news.